Immunological consequences of mesenchymal stem cell therapy in HPV-driven cervical cancer: a systematic review and stratification framework.
Over 660,000 women develop cervical cancer annually, caused by persistent infection with high-risk human papillomavirus (HPV). Published studies of mesenchymal stem/stromal cells (MSCs) as immunomodulatory agents are contradictory, with some reporting tumor suppression and others tumor promotion. The mechanism of these...